Table 3.

Periprocedural antithrombotic management and ischemic complications

Management	All	Ischemic event	No ischemic event	P-value
Preprocedural antiplatelet regimen
None	48	7 (14.5)	41 (85.4)	0.83
Single antiplatelet therapy	68	11 (16.1)	57 (83.8)
Dual antiplatelet therapy	150	29 (19.3)	121 (80.6)
Triple antiplatelet therapy	8	1 (12.5)	7 (87.5)
Postprocedural anticoagulation
None	109	12 (11.0)	97 (88.9)	0.14
Heparin	59	13 (22.0)	46 (77.9)
Argatroban	106	23 (21.7)	83 (78.3)
Postprocedural antiplatelet regimen
None	44	5 (11.3)	39 (88.6)	0.40
Single antiplatelet therapy	73	11 (15.0)	62 (84.9)
Dual antiplatelet therapy	148	31 (20.9)	117 (79.0)
Triple antiplatelet therapy	9	1 (11.1)	8 (88.8)